These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28007549)

  • 21. Exploring the Seasonal Drivers of Varicella Zoster Virus Transmission and Reactivation.
    Bakker KM; Eisenberg MC; Woods R; Martinez ME
    Am J Epidemiol; 2021 Sep; 190(9):1814-1820. PubMed ID: 33733653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Epidemiology of Herpes Zoster After Varicella Immunization Under Different Biological Hypotheses: Perspectives From Mathematical Modeling.
    Guzzetta G; Poletti P; Merler S; Manfredi P
    Am J Epidemiol; 2016 Apr; 183(8):765-73. PubMed ID: 26994062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. VZV-specific cell-mediated immunity, but not humoral immunity, correlates inversely with the incidence of herpes zoster and the severity of skin symptoms and zoster-associated pain: The SHEZ study.
    Asada H
    Vaccine; 2019 Oct; 37(44):6776-6781. PubMed ID: 31543415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
    Bonmarin I; Santa-Olalla P; Lévy-Bruhl D
    Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom.
    van Hoek AJ; Melegaro A; Gay N; Bilcke J; Edmunds WJ
    Vaccine; 2012 Feb; 30(6):1225-34. PubMed ID: 22119592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Universal varicella vaccination: efficacy trends and effect on herpes zoster.
    Goldman GS
    Int J Toxicol; 2005; 24(4):205-13. PubMed ID: 16126614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study.
    Thomas SL; Wheeler JG; Hall AJ
    Lancet; 2002 Aug; 360(9334):678-82. PubMed ID: 12241874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serology indicates cytomegalovirus infection is associated with varicella-zoster virus reactivation.
    Ogunjimi B; Theeten H; Hens N; Beutels P
    J Med Virol; 2014 May; 86(5):812-9. PubMed ID: 24037981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiological characteristics and societal burden of varicella zoster virus in the Netherlands.
    Pierik JG; Gumbs PD; Fortanier SA; Van Steenwijk PC; Postma MJ
    BMC Infect Dis; 2012 May; 12():110. PubMed ID: 22574722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modelling the impact of varicella vaccination on varicella and zoster.
    Karhunen M; Leino T; Salo H; Davidkin I; Kilpi T; Auranen K
    Epidemiol Infect; 2010 Apr; 138(4):469-81. PubMed ID: 19796447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A systematic review and meta-analysis of seroprevalence of varicella zoster virus: A nationwide population-based study.
    Amjadi O; Rafiei A; Haghshenas M; Navaei RA; Valadan R; Hosseini-Khah Z; Omran AH; Arabi M; Shakib RJ; Mousavi T; Ashrafi GH
    J Clin Virol; 2017 Feb; 87():49-59. PubMed ID: 28011413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005-2009.
    Weinmann S; Chun C; Schmid DS; Roberts M; Vandermeer M; Riedlinger K; Bialek SR; Marin M
    J Infect Dis; 2013 Dec; 208(11):1859-68. PubMed ID: 23922376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modelling the impact of vaccination on the epidemiology of varicella zoster virus in Australia.
    Gidding HF; Brisson M; Macintyre CR; Burgess MA
    Aust N Z J Public Health; 2005 Dec; 29(6):544-51. PubMed ID: 16366065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England.
    van Hoek AJ; Melegaro A; Zagheni E; Edmunds WJ; Gay N
    Vaccine; 2011 Mar; 29(13):2411-20. PubMed ID: 21277405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seroprevalence and molecular characteristics of varicella-zoster virus infection in Chinese children.
    Luan L; Shen X; Qiu J; Jing Y; Zhang J; Wang J; Zhang J; Dong C
    BMC Infect Dis; 2019 Jul; 19(1):643. PubMed ID: 31324226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review.
    Reynolds MA; Chaves SS; Harpaz R; Lopez AS; Seward JF
    J Infect Dis; 2008 Mar; 197 Suppl 2():S224-7. PubMed ID: 18419401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Varicella-zoster virus vaccination under the exogenous boosting hypothesis: two ethical perspectives.
    Luyten J; Ogunjimi B; Beutels P
    Vaccine; 2014 Dec; 32(52):7175-8. PubMed ID: 25454883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insights on the Impact of External and Internal Boosting on Varicella-Zoster Virus Reactivation Based on Evidence From the First Decade of the United States Universal Varicella Vaccination Program.
    Goldman GS
    Cureus; 2021 Aug; 13(8):e16963. PubMed ID: 34373828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrating between-host transmission and within-host immunity to analyze the impact of varicella vaccination on zoster.
    Ogunjimi B; Willem L; Beutels P; Hens N
    Elife; 2015 Jul; 4():. PubMed ID: 26259874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An ODE-based mixed modelling approach for B- and T-cell dynamics induced by Varicella-Zoster Virus vaccines in adults shows higher T-cell proliferation with Shingrix than with Varilrix.
    Keersmaekers N; Ogunjimi B; Van Damme P; Beutels P; Hens N
    Vaccine; 2019 May; 37(19):2537-2553. PubMed ID: 30975567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.